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BAC recombinationIdentiﬁcation of multipotent cardiac progenitors has provided important insights into the mechanisms of
myocardial lineage speciﬁcation, yet has done little to clarify the origin of the endocardium. Despite its
essential role in heart development, characterization of the endocardial lineage has been limited by the lack
of speciﬁc markers of this early vascular subpopulation. To distinguish endocardium from other vasculature,
we generated an NFATc1-nuc-LacZ BAC transgenic mouse line capable of labeling this speciﬁc endothelial
subpopulation at the earliest stages of cardiac development. To further characterize endocardiogenesis,
embryonic stem cells (ESCs) derived from NFATc1-nuc-LacZ blastocysts were utilized to demonstrate that
endocardial differentiation in vitro recapitulates the close temporal–spatial relationship observed between
myocardium and endocardium seen in vivo. Endocardium is speciﬁed as a cardiac cell lineage, independent
from other vascular populations, responding to BMP and Wnt signals that enhance cardiomyocyte
differentiation. Furthermore, a population of Flk1+ cardiovascular progenitors, distinct from hemangioblast
precursors, represents a mesodermal precursor of the endocardial endothelium, as well as other
cardiovascular lineages. Taken together, these studies emphasize that the endocardium is a unique cardiac
lineage and provides further evidence that endocardium and myocardium are derived from a common
precursor.© 2009 Published by Elsevier Inc.IntroductionPrecise coordination of several distinct cell lineages is required for
heart development. The cardiac precursors of the ﬁrst and second
heart ﬁelds, having passed through the primitive streak during
gastrulation, populate a region of anterior mesoderm known as the
cardiac crescent (Buckingham et al., 2005; Kirby, 2002). With lateral
folding, these precursors coalesce into a linear heart tube composed of
an outer myocardium and inner endocardium. This tube serves as the
structural basis for subsequent morphogenesis, as migrating neural
crest and proepicardium contribute to vital structural features of the
outﬂow tract and coronary vasculature (Brown and Baldwin, 2006;
Mikawa and Gourdie, 1996). Genetic analyses and fate mapping have
documented the origins and functions of these cell lineages in
cardiogenesis with one notable exception. Despite being one of thel Center, Pediatric Cardiology –
ille, TN 37232-0493, USA. Fax:
aldwin).
lsevier Inc.earliest cardiac populations, little is known about the origin of the
endocardium.
Endocardial cells ﬁrst emerge from the ventral surface of the
cardiac mesoderm into the space between myocardial cells and
anterior visceral endoderm. With tubular heart formation, myogenic
epithelium retains N-cadherin while endocardial precursors down-
regulate expression (Linask, 1992). At this stage of development,
endocardial cells are distinguished from myocardium by the expres-
sion of vascular makers, such as Flk1 (VEGFR-2), CD31/Pecam-1, and
VE-cadherin (Baldwin, 1996; Drake and Fleming, 2000). The endo-
cardium is unique from other endothelium both in terms of this
developmental relationship with myocardium, but also in its critical
role in valvulogenesis and trabeculation. Valve formation is initiated
when endocardial cells delaminate into the underlying cardiac jelly, a
process termed epithelial-to-mesenchymal transition (EMT) (Barnett
and Desgrosellier, 2003). Failure to undergo EMT or disruption of
signals from the endocardium to cushion cells results in a variety of
valve defects. In myocardial trabeculation, loss of Neuregulin in
ventricular endocardium or its myocardial receptors ErbB2/ErbB4
results in an absence of trabeculation and decreased myocyte
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Birchmeier, 1995).
Whether endocardium and myocardium share a common pro-
genitor in the cardiac mesoderm remains controversial, with existing
models predicting either a common multipotent progenitor or two
spatially sequestered subpopulations within the cardiac crescent.
Recent evidence from zebraﬁshmodels suggests that endocardial cells
are derived from the hematopoietic and vascular lineage, and then
migrate to invest the developing myocardial tube (Bussmann et al.,
2007). Retroviral tracing in the avian embryo indicates that these two
populations are distinct prior to gastrulation (Cohen-Gould and
Mikawa, 1996; Wei and Mikawa, 2000). In contrast, growing evidence
suggests endocardium and myocardium are derived from a common
multipotent mesodermal progenitor in the mouse. Fate mapping
analyses in mice indicate mesodermal cells expressingMesp1 and Flk1
contribute to both endocardium and myocardium (Motoike et al.,
2003; Saga et al., 2000). Cre-mediated lineage tracing of Nkx2.5+ and
Isl1+ cardiac populations suggest that as late as the cardiac crescent,
subsets of myocardium, endocardium, vascular endothelium, and
smoothmuscle are derived from a commonprecursor (Cai et al., 2003;
Stanley et al., 2002). These ﬁndings imply a close developmental
relationship between the endocardium and myocardium, but detailed
examination has proven difﬁcult due to the limitations of in vivo
mouse models.
Since its initial description, embryonic stem cell (ESC) differentia-
tion has emerged as a robust in vitromodel of lineage speciﬁcation, as
mesodermal derivatives such as endothelium, hematopoietic cells,
and cardiomyocytes develop in a sequential pattern mirroring
embryonic development (Keller, 2005). ESC differentiation has
previously been utilized to deﬁne the origin and speciﬁcation of the
mesodermal hemangioblast, a common hematopoietic and endothe-
lial precursor (Choi et al., 1998; Nishikawa et al., 1998). Recent studies
of cardiac speciﬁcation in ESC differentiation models have clariﬁed
the progression of lineage commitment required to establish
cardiovascular cell populations. From ESCs expressing GFP under
the mesodermal gene Brachyury, a Flk1+ multipotent cardiovascular
progenitor capable of generating cardiomyocytes, smooth muscle
cells, and endothelium were characterized (Kattman et al., 2006).
Other approaches, using the early cardiac markers Isl1 and Nkx2.5,
have also isolated progenitor populations possessing various levels of
cardiovascular cell potency (Christoforou et al., 2008; Moretti et al.,
2006; Wu et al., 2006). However, the lack of a speciﬁc marker for the
early endocardium prevents direct examination of the endocardium
in these studies, and consequently, they failed to draw a distinction
between the endocardium and other endothelium.
Taking advantage of our previous observation that Nuclear Factor
of Activated T-cells (NFATc1/NFAT2) is an endocardial-speciﬁc
transcription factor during early cardiac development, we investigated
the existence of a common endocardial–myocardial progenitor by
generating a bacterial artiﬁcial chromosome (BAC) transgene contain-
ing the NFATc1 genomic locus (de la Pompa et al., 1998; Ranger et al.,
1998). Possessing the regulatory elements necessary to distinguish
endocardium from other endothelium, this NFATc1-nuc-LacZ BAC
transgenic mouse faithfully recapitulated endogenous endocardial
NFATc1. Using ES cells derived from NFATc1-nuc-LacZ BAC transgenic
embryos, we demonstrate endocardiogenesis in ESC differentiation
and document the close temporal–spatial relationship seen between
endocardium and myocardium in vivo is reproduced in vitro. We show
endocardium is derived from a speciﬁc mesodermal population as a
cardiac cell lineage distinct from hematopoietic and vascular lineages.
Furthermore, clonal analysis established this population contains
cardiovascular progenitorswith cardiomyocyte, endocardial, endothe-
lial, and smooth muscle potential. Collectively, these studies provide
evidence that endocardium is a unique cardiac lineage distinct from
other endothelium, and that endocardium and myocardium are
derived from a common cardiovascular progenitor.Materials and methods
BAC targeting and transgenesis
To generate the NFATc1-nuc-LacZ BAC transgene, a nuclear-
localized LacZ reporter (nuc-LacZ) and a frt ﬂanked tetracycline
resistance cassette (TetR) were inserted between homology arms
corresponding to the 500 bp 5′ of the translational start site and
400 bp 3′ to the splice site of Exon1. Bacterial homologous
recombination was performed as previously described (Lee et al.,
2001). To establish transgenic mouse lines, the NFATc1-nuc-LacZ BAC
transgene was prepared by cesium chloride gradient puriﬁcation, and
dialyzed into microinjection buffer (10 mM Tris, 15 μM EDTA pH 7.4)).
BAC DNAwas diluted to 2 ng/μl for injection into pronuclei of 0.5-day-
old fertilized FVB zygotes and transferred into oviducts of pseudo-
pregnant ICR females (Boyle et al., 2008). Animals were maintained in
accordance with protocols approved by the Vanderbilt University
Institutional Animal Care and Use Committee (IACUC).
Embryonic stem cell culture and differentiation
ESCs were cultured on irradiated mouse embryonic ﬁbroblasts in
Dulbecco's Modiﬁed Eagle Medium (DMEM) supplemented with 15%
FBS (HyClone), 2 mM L-glutamine, 100 U/ml Pen/Strep, 1 mM sodium
pyruvate, 100 μM non-essential amino acids, 1000 U/ml recombinant
leukemia inhibitory factor (ESGRO, Millipore) and 100 μM β-
mercaptoethanol. ESCs were transferred to gelatinized plates 1–
2 days prior to the initiation of differentiation. Embryoid bodies (EBs)
were formed by either hanging drop or in suspension at a density of
2.5×10−4 in ESC differentiation media (DM) consisting of Iscove's
Modiﬁed Dulbecco's Medium (IMDM) supplemented with 15% FBS,
2 mM L-glutamine, 100 U/ml Pen/Strep, 200 μg/m transferrin
(Roche), 0.5 mM L-ascorbic acid (Sigma), and 4.5×10−4 M mono-
thioglycerol. Noggin/Fc, Wnt3A, Dkk-1 were obtained from R&D
Systems. ESC lines from NFATc1-nuc-LacZ BAC transgenics were
derived from E3.5 blastocyst-stage embryos plated on irradiated STO
feeders in RESGRO complete ES medium (Millipore). After 5–6 days in
culture, the inner cell mass outgrowth was selectively removed from
the trophectoderm, trypsinized, and then replated (Liu and Labosky,
2008). Once colonies were visible, ESCs were transitioned to ES
medium.
β-galactosidase and immunostaining
For immunoﬂuorescence, embryo cryosections (10 μm) were ﬁxed
in 10% neutral buffered formalin (NBF); cells in culture were ﬁxed
with ice cold methanol:acetone (1:1). Tissues were blocked in 10%
goat serum (Jackson Labs) prior to incubationwith primary antibodies
overnight at 4 °C. Antibodies used are listed in Supplemental
experimental procedures. Samples were mounted with Vectashield
containing DAPI (Vector Labs). Images were acquired using a Nikon
Eclipse E800 epiﬂuorescence microscope or Zeiss Upright LSM510
Confocal Microscope. MetaMorph v6.1 (Molecular Devices) was used
to calculate MHC+ area per EB. For β-Galactosidase staining, whole-
mount embryos, cryosections, and cells in culturewere ﬁxedwith 0.2%
glutaraldehyde, 2 mM MgCl2, and 5 mM EGTA in PBS, or 10% NBF for
dual β-Gal/immunoperoxidase staining, and stained with 1 mg/ml X-
Gal and 5mMpotassium ferro/ferricyanate, 2 mMMgCl2, 0.02% NP40,
0.01% sodium deoxycholate in PBS.
Flow cytometry
D3.5 EBs were dissociated using cell disassociation buffer (Gibco)
and resuspended in Hanks Buffered Salt Solution (HBSS) with 2% FBS,
and 25 mM HEPES. Samples were then incubated with CD16/CD32
(mouse, Ebioscence, 1 μg/ml) to block nonspeciﬁc binding prior to
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1 μg/ml) and E-cadherin (rat DECMA, Sigma, 1 μg/ml). Cells were
sorted on a FACSAria (Becton Dickinson) using FACSDiva 6.0 for data
collection. Dead cells stained with propidium iodide (Molecular
Probes) were excluded from analysis.
Cardiac colony assays
Sorted cells were plated at a density of 1–10×103 cells/cm3 onto
OP9 stromal cells, maintained as previously described (Kodama et al.,
1994). For secondary Flk1 sorting, cells were grown for 24 h on OP9
stromal cells in serum-free DM with 15% Knockout Serum replace-
ment (Invitrogen), bFGF (30 ng/ml) and VEGF (5 ng/ml) (R&D
Systems). Resorted Flk1 positive and negative cells were plated at aFig. 1. Generation of NFATc1-nuc-LacZ BAC transgenic mice. (A) In situ hybridization depictin
outﬂow tract, oft; common ventricle, v; aortic sac, as; atria, a. (B) Schematic of the mouse N
conﬁrmed by NotI digestion with subsequent Southern blotting for LacZ. NotI, N; AscI, A. (
crescent (white arrowheads). (D, E) Coronal section of β-gal+ endocardial cells position
precursors, mp; endocardial precursor, ep; neuroectoderm, ne; cardiac crescent, cc;
immunohistochemistry for myosin heavy chain (MHC; reddish-brown) marking myocardia
E7.75 X-Gal stained transgenic embryo. (G) E8.5 whole-mount X-Gal stained transgenic e
situ for the endothelial marker CD31/Pecam-1 displaying the entirety of the embryonic va
da; cardiac crescent, yolk sac, ys. (I) Coronal section of E8.5 X-Gal stained NFATc1-nuc
myocardial layer.density of 1×103 cells/cm3 in serum-free medium supplemented
with VEGF (5 ng/ml), bFGF (30 ng/ml), BMP4 (50 ng/ml), and Dkk-1
(150 ng/ml). Contracting colonies were scored after 6 days in culture.
For clonal expansion, single Flk1+ cells were distributed by ﬂow
cytometry into 96-well plates seeded with OP9 stromal cells. After
7 days in culture, the cells were ﬁxed, stained, and scored.
Gene expression analysis
Total RNA was extracted using Trizol (Invitrogen), then treated
with Turbo DNA-free (Applied Biosystems) before additional puriﬁca-
tion with RNeasy Mini (Qiagen). RNA was reverse-transcribed into
cDNA using the High Capacity cDNA Reverse Transcription kit
(Applied Biosystems). RT-PCR was performed using REDTaq (Sigma)g endocardial NFATc1 (magenta) expression at E9.5. Myocardium, m; endocardium, e;
FATc1 BAC locus and nuclear-localized LacZ BAC targeting vector. Proper targeting was
C) X-Gal stained E7.75 NFATc1-nuc-LacZ embryo with β-gal expression in the cardiac
ed directly between the anterior endoderm and myocardial precursors. Myocardial
anterior visceral endoderm, ave; intraembryonic coelom, iec. (F) Whole-mount
l cells and β-gal+ endocardial cells in the cardiac crescent (white arrowheads) of an
mbryo with β-gal expression conﬁned to the linear heart tube. (H) Whole-mount in
sculature at the E8.5 linear heart stage. Endocardium, e; heart tube, ht; dorsal aorta,
-LacZ embryo documenting β-gal expression in the endocardial layer, and not the
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conditions: 94 °C for 2 min, followed by 30 cycles of ampliﬁcation
(94 °C denaturation for 30 s, 60 °C annealing for 30 s, 72 °C elongation
for 60 s), then a ﬁnal incubation at 72 °C for 10 min. Quantitative Real-
time PCR was performed on a Roche LightCycler System using
FastStart DNA MasterPLUS SYBR Green I (Roche). Each sample was
done in triplicate and relative expressionwas calculated as Δ2−ct with
HPRT as an internal control.
Results
Generation of NFATc1-nuc-LacZ BAC transgenic mice
NFATc1 expression is present in all endocardial cells of the primitive
heart tube (Fig. 1A). To identify endocardial cells differentiating from
cardiac mesoderm, we employed BAC recombineering to generate an
NFATc1 reporter transgene to maximize utilization of critical genomic
regulatory elements. We inserted a nuc-LacZ cassette into a BAC clone
possessing the NFATc1 genomic locus and 50–75 kb surrounding
sequence (Fig. 1B). Pronuclear injection of ∼200 zygotes resulted in 18
live births, 3 of which were determined by PCR to carry the nuc-LacZ
gene (data not shown). Beta-galactosidase (β-gal)wasﬁrst detected in
the anterior portion of the E7.75 embryo at the cardiac crescent stage
(Fig. 1C, white arrowheads). In coronal sections of E7.75 transgenic
embryos, nuclear-localized β-gal is restricted to endocardial precur-
sors at the cardiac crescent that are organized as a distinct plate of cells
positioned directly between the AVE andmyocardial precursors rather
than being interspersed with primitive cardiomyocytes (Figs. 1D, E).Fig. 2. Expression of the NFATc1-nuc-LacZ BAC transgene during cardiogenesis. (A, B) E9.5 X-
gal expression in the endocardium of the looped heart tube (white arrowheads), but in no o
avc. (C, D) LacZ reporter gene expression in sagittal cryosections of E10.5 (C) and E11.5 (
endocardial cells having undergone EMT to populate the cushions. Expression is absent in th
ventricle, v; endocardial cushions, ecc. (E, F) After septation, β-gal expression is only evide
arrowheads). Left atria, la; left ventricle, lv; mitral valve, mv; aortic valve, av; aorta, ao; pul
NFATc1-nuc-LacZ heart demonstrating cellular co-localization of endogenous endocardial NFE7.75 X-Gal stained transgenic embryoswhole-mount immunostained
for myosin heavy chain (myosin heavy chain; MHC) further clariﬁed
that endocardial and myocardial precursors were dispersed through-
out the cardiac crescent as the two populations migrate towards the
midline to generate the primitive heart tube (Fig. 1F).
At E8.25, whenmerging of the bilateral precursors of the ﬁrst heart
ﬁeld (FHF) forms the linear primitive heart, β-gal expression was
entirely localized to the endocardium (Fig. 1G). No expression was
evident in the systemic vasculature, as illustrated by the comparison
of a whole-mount stained E8.25 NFATc1-nuc-LacZ BAC transgenic
embryo against a comparable embryo whole-mount in situ stained for
the endothelial marker CD31/Pecam-1 (Fig. 1H). X-Gal staining in
coronal sections through the length of the linear heart demonstrates
β-gal is limited to the endocardial tube and not in the surrounding
myocardium (Fig. 1I). These ﬁndings indicate the NFATc1-nuc-LacZ
BAC transgene speciﬁcally identiﬁes the entire subpopulation of
endocardial endothelium at its earliest stage of development as they
differentiate in the cardiac mesoderm.
NFATc1-nuc-LacZ BAC expression reproduces endogenous NFATc1
expression during cardiogenesis
Given NFATc1's dynamic expression in endocardial cells across the
window of cardiac development, we assessed β-gal expression during
early murine embryogenesis. At E9.5, β-gal was detected in all
portions of the endocardium (Figs. 2A, B). Robust expression was
observed in the primitive atria and ventricle, the atrioventricular canal
(AVC) and outﬂow ﬂow tract (OFT), but was mosaic in the proximalGal stained whole-mount (A) and cryosectioned (B) NFATc1-nuc-LacZ embryos with β-
ther embryonic endothelium. Myocardium, m; endocardium, e; atrioventricular canal,
D) hearts is restricted to endocardium overlying the cushions, with no expression in
e atrial and ventricular endocardium (white arrowheads). Outﬂow tract, oft; common
nt in the endocardium of remodeling valves, and in no other endocardial cells (white
monary valve, pv; right ventricle, rv; trabeculae, t. (G) Immunoﬂuorescence of an E9.5
ATc1 (green) and β-gal (red). Nuclei were detected with DAPI (blue).
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cushion formation was initiated at E10.5, β-gal was downregulated in
the atrial and ventricular endocardium, yet retained in the endocar-
dium overlying the valve cushions not undergoing EMT (Fig. 2C). This
process of restriction was complete by E11.5, with cardiac expression
of the transgene limited to only the endocardium of the remodeling
valves, in agreement with prior descriptions of the expression and
function of NFATc1 (Fig. 2D) (Chang et al., 2004; Lange and Yutzey,
2006; Zhou et al., 2005). β-gal was expressed on all four valve
cushions formed with the onset of chamber septation at E12.5 (Figs.
2E, F). During valve remodeling and elongation, β-gal was retained in
this endocardial subpopulation, and was undetectable by E16.5 (data
not shown).
Co-expression of NFATc1 and β-gal in the E9.5 endocardium
conﬁrmed that transcription of LacZ from the BAC transgene
recapitulated the endogenous regulation of NFATc1 (Fig. 2G). Co-
immunoﬂuorescence of β-gal with endothelial and myocardial
markers demonstrated that β-gal identiﬁed a cardiac subpopulation
of endothelium (VE-cadherin+) that did not overlap with myocar-Fig. 3. Dynamics of endocardium and myocardium differentiation during in vitro embryon
mesodermal derivatives, speciﬁcally endocardial (NFATc1), myocardial (Nkx2.5, βMHC) and
are normalized to 1 based on peak expression values of that gene to yield qualitative re
cardiomyocyte (MHC, red), endothelial (CD31/Pecam-1, blue, white arrows) and endocard
endocardial cells represent a subset of all endothelial cells restricted to regions adjunct to my
epithelial-like sheet in close association with immature MHC+ cardiomyocytes (C). With th
myoﬁbrils and sarcomeres at D11, NFATc1+/CD31+ endocardial cells could still be detected
detected in regions lacking cardiomyocyte differentiation at any of these time points. (E) D9
nuclear β-gal restricted to endothelial cells. Nuclei were detected with DAPI (blue). (F) Dual
ESCwith β-gal+ endocardial cells adjacent to sites of myocardial differentiation (cTnT, brown
transgenic ESCs with β-gal+/CD31+ endocardial cells present in close proximity to myocadium (cardiac troponin T; cTnT) (Fig. S1). In addition to its cardiac
expression, expression in other cell populations could be observed
after E11.5, most notably in the cartilaginous condensations of the
limb, prevertebral bodies, and ribs, as well as in the whisker follicles,
all cell populations where NFATc1 plays a critical developmental role
(Fig. S2) (Horsley et al., 2008; Winslow et al., 2006). Taken together,
these data conﬁrm that the NFATc1-nuc-LacZ BAC transgene faithfully
recapitulates endogenous NFATc1 expression.
Endocardial cells differentiate as a mesodermal-derived cardiovascular
cell population
As ESC differentiation has been widely used to study cardiomyo-
cyte lineage determination, we investigated its ability to model
endocardial differentiation. Gene expression analysis by quantitative
real-time PCR (qRT-PCR) indicated NFATc1, absent in undifferentiated
ESCs and early differentiating embryoid bodies (EBs), was ﬁrst
upregulated at differentiation day 6 (D6), reaching its highest
expression at D8–D10 (Fig. 3A). In contrast, Brachyury (T), a transientic stem cell culture. (A) Gene expression proﬁles of mesoderm (Brachyury, Flk1) and
vascular lineages (VE-cadherin, CD31, Flk1) during ESC differentiation. Individual values
presentations of expression trends. (B–D) Immunoﬂuorescence images documenting
ial (NFATc1, green, white arrowheads) differentiation in EBs. At D8, NFATc1+/CD31+
ocardial differentiation (B). By D9, NFATc1+/CD31+ endocardial cells form a condensed
e maturation of cardiomyocytes into elongated, contracting cells with well-developed
at sites of myocardial differentiation (D). NFATc1+/CD31+ endocardial cells were not
EB from NFATc1-nuc-LacZ derived ESC stained with a β-gal (green) and CD31 (red) with
β-gal/immunoperoxidase staining performed on D9 EBs from NFATc1-nuc-LacZ derived
). (G) Co-immunostaining for β-gal (green), MHC (red), and CD31 (blue) in D9 EBs from
rdium, and not in regions lacking cardiomyocytes.
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sharply reduced by D6. This indicates NFATc1 expression, and by
association endocardial differentiation, occurs subsequent to meso-
dermal speciﬁcation. The temporal expression of NFATc1 was similar
to genes expressed by differentiating myocardium, such as Nkx2.5, an
early myocardial transcript that is observed in the FHF at the crescent
stage in vivo and was upregulated at D6 in vitro, and βMHC, encoding a
ventricular myocardial speciﬁc isoform of myosin heavy chain that
was ﬁrst expressed at D8 in vitro, coinciding with the appearance of
contracting foci within EBs (Fig. 3A). In addition, NFATc1's expression
coincided with vascular markers VE-cadherin and the later phase of
CD31/Pecam-1 expression, but lagged behind Flk-1, which marks
both mesoderm and early endothelial populations. These ﬁndings
demonstrate that the temporal kinetics of NFATc1 expression in
differentiating ESCs are consistent with its expression during
cardiogenesis in vivo.
While ESC-derived EBs exhibit a pattern of sequential lineage
progression that recapitulates in vivo development, EBs have been
generally considered to lack the spatial complexity normally seen
in embryogenesis. However, recent observations suggest that
certain interactions between different cell populations might be
required for proper differentiation in EBs (Ogawa et al., 2005;
White and Claycomb, 2005). To explore whether spatial relation-
ships between cardiovascular cell populations exist in ESC
differentiation, we conducted immunoﬂuorescence studies of EBs
at the onset of cardiac differentiation as determined by qRT-PCR.
Using markers for early myocardium (MHC), endothelium (CD31),
and endocardium (NFATc1), we observed that at D8 NFATc1+/
CD31+ cells were restricted to regions adjunct to myocardial
differentiation (Fig. 3B). Association between endocardium and
myocardium was consistent from when MHC was ﬁrst detectable at
D8, through the formation of larger contacting foci at D11. With
maturation of cardiomyocytes, NFATc1+/CD31+ endocardial cells
transitioned from a diffuse vascular plexus to a condensed
epithelial-like sheet, but maintained their close association with
MHC+ cardiomyocytes (Figs. 3C, D). Immunoﬂuorescence studies
with the NFATc1 antibody conducted prior to D8 were inconclusive,
possibly due to the level of NFATc1 expression or the inefﬁciency of
the NFATc1 antibody.
To further evaluate the temporal and regional differentiation of
endocardium in vitro, ESC lines were derived from E3.5 blastocysts
carrying the NFATc1-nuc-LacZ BAC transgene. Upon differentiation, β-
gal expression was ﬁrst observed at D6 (Fig. S3). By D9, β-gal+ cells
had increased in number and were consolidated in patches of cells,
similar to what was observed in earlier immunoﬂuorescence studies
with NFATc1+/CD31+ cells. After D12, β-gal+ cells were noticeably
reduced and dispersed throughout the EB. The temporal expression of
NFATc1-nuc-LacZ in EBs matched NFATc1's documented pattern from
qRT-PCR analysis (Fig. 3A). Immunostaining of D9 EBs detected
nuclear β-gal restricted to CD31+ endothelial cells (Fig. 3E). Dual β-
gal/immunoperoxidase staining conﬁrmed that β-gal+ cells were
spatially localized to sites of myocardial differentiation (Fig. 3F).
NFATc1+ cells were seldom detected in regions lacking cardiomyo-
cytes, and non-endothelial NFATc1 expression was not observed over
the period of differentiation investigated.
To further conﬁrm that the NFATc1 BAC reporter uniquely
identiﬁed endocardial cells and was not expressed in other cell
populations, EBs generated from an ESC line containing an NFATc1-
mCherry BAC were sorted by ﬂow cytometry. At D9, all NFATc1+ cells
(4.7%) were CD31/Pecam-1+ endothelial cells (Fig. S4). EBs immu-
nostained for cardiomyocytes, endothelium, and endocardium, con-
ﬁrmed that β-gal+/CD31+ endocardial cells were only differentiated
in close proximity to myocardium (Fig. 3G). Taken together, β-gal
expression from the NFATc1-nuc-LacZ BAC transgene reﬂects NFATc1
expression, allowing LacZ staining to be reliably used to monitor
endocardial speciﬁcation in ESC differentiation.Endocardial cells respond to BMP and Wnt signaling as a cardiac lineage
To evaluate whether endocardium is speciﬁed as a specialized
cardiac cell or a spatially distinct endothelial cell, differentiating ESCs
were treated with soluble factors shown to affect cardiac or
hematopoietic/vascular development (Fig. 4A). Under the early
treatment paradigm, EBs were treated with recombinant Noggin/Fc
(150 ng/ml) in serum-containing differentiation medium (DM) from
day 0 until plating at day 4 (Lindsley et al., 2006). BMP signaling has
been implicated in extraembryonic mesoderm development and
hematopoiesis, while its inhibitor, Noggin, has been shown to enhance
cardiomyocyte speciﬁcation in ESC differentiation (Snyder et al., 2004;
Yuasa et al., 2005). Late treatments with eitherWnt3A (100 ng/ml) or
the Wnt inhibitor Dickkopf-1 (Dkk-1; 200 ng/ml) were added to DM
at day 5 until day 7. Wnt signaling is an effective modulator of gene
expression in numerous cell lineages and its activation/inhibition
exhibits opposing effects on cardiac and hematopoietic/vascular
speciﬁcation (Naito et al., 2006).
Early Noggin/Fc exposure signiﬁcantly enhanced cardiomyocyte
differentiation, measured by changes in MHC+ area, with an approx-
imate 3-fold increase over controls (16.2%±3.2% vs. 6.0%±1.2%)
consistent with previous studies. Dkk-1 treatment at D5 had a similar
effect (11.4%±1.6%), while late Wnt activation with Wnt3A sup-
pressedmyocyte formation (2.6%±0.5%) (Figs. 4B, C). QuantitativeRT-
PCR conﬁrmed an inverse relationship between cardiac cells and the
hematopoietic/vascular lineage. Markers of cardiomyocyte speciﬁca-
tion and maturation, Nkx2.5 and cTnT, were upregulated with early
Noggin/Fc and late Dkk-1, while suppressed with Wnt3A. Vascular
(CD31, VE-cadherin) and hematopoietic (βH1-globin, GATA1) markers
were upregulated with late-phase addition of Wnt3A (Fig. 4D).
Given the relationship between cardiomyocytes and endocardial
cells in EBs, we hypothesized that an increase in endocardium would
accompany myocyte enrichment. NFATc1-nuc-LacZ BAC ESCs were
differentiated to examine endocardiogenesis by immunoﬂuorescence.
β-gal+/CD31+ endocardial cells increased with early addition of
Noggin/Fc or late Dkk-1. There was a noticeable decrease in vascular
plexus formation, though β-gal+/CD31+ endocardial cells were still
present (Fig. 4C, compare panel i vs. ii and iv). This pattern was
reversed with Wnt3a, where myocardium and endocardium were
largely absent (Fig. 4C, panel iii). NFATc1, as a marker of endocardium,
increased with Noggin/Fc and Dkk-1 similar to myocytes, not with
other endothelial cells (Fig. 4C, panels ii and iv). These ﬁndings
indicate endocardium is speciﬁed by signals that direct the speciﬁca-
tion of cardiac cell types, not ones that impact the hematopoietic/
vascular lineage. As growth factor treatment is effective prior to the
emergence of cardiac cell types, it suggests that BMP and Wnt
signaling acts on a precursor population of endocardium and
myocardium, but does not clarify whether endocardial cells are
derived from the same common precursor as cardiomyocytes or
develop in a parallel and dependent pathway.
Endocardium is speciﬁed as a cardiac lineage distinct from vascular
endothelium
Although our data fromNoggin/Fc and Dkk-1 treated EBs indicates
endocardium is speciﬁed as a cardiac cell type distinct from peripheral
vasculature, a level of uncertainty is introduced by conducting these
studies using whole EBs. To more precisely deﬁne endocardiogenesis
from mesodermal populations as it relates to cardiomyocyte and
hematopoietic/vascular differentiation, we sorted EBs at D3.5 with
the cell surface markers Flk1 and E-cadherin. Lineage tracing studies
have shown components of the cardiovascular system are derived
from Flk1+ mesoderm (Ema et al., 2006; Fehling et al., 2003). In
addition, exfoliating mesodermal cells downregulate E-cadherin
(ECD) as they exit the primitive streak (Ciruna and Rossant, 2001;
Huber et al., 1996). Three distinct populations of cells were present in
Fig. 4. Effect of BMP and Wnt signaling on cardiac, hematopoietic, and vascular speciﬁcation. (A) NFATc1-nuc-LacZ derived ESCs were differentiated with recombinant Noggin/Fc
(150 ng/ml) from D0 through D4, or Wnt3A (100 ng/ml) or Dkk-1 (200 ng/ml) from D5–D7. (B) Individual EBs from different treatments were plated into 24-well dishes and
subjected to morphometric analysis of MHC at D10. Values represent the ratio of MHC+ area to total EB area. ⁎=pb .05 vs. control, N=8. Error bars indicate SEM. Early Noggin/Fc
and late Dkk-1 exposure signiﬁcantly enhanced cardiomyocyte differentiation, while late Wnt activation with Wnt3A suppressed myocyte speciﬁcation. (C) Representative images
from control (i), Noggin/Fc (ii), Wnt3A (iii), and Dkk-1 treated D10 NFATc1-nuc-LacZ derived EBs stained for β-gal (green, white arrowheads), MHC (red), and CD31 (blue, white
arrows). β-gal+/CD31+ endocardial cells increased with early addition of Noggin/Fc or late Dkk-1. Scale bars equal 200 µm. (D) Fold change in expression of endocardial (NFATc1),
cardiac (Nkx2.5, cTnT), vascular (CD31, VE-cadherin) and hematopoietic (βH1-globin, GATA1) genes at D10. Error bars indicate SEM.
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ECD were not co-expressed at high levels (Fig. 5A; Fig. S5). Isolated
ECDhighFlk1low cells expressed the primitive ectoderm marker Rex1,
the neuroectodermal gene, Pax6, and markers of endoderm/mesen-
doderm, Sox17 and FoxA2. The ECDlowFlk1high fraction lacked these
markers and instead possessed markers of the early hematopoietic/
vascular lineage (Runx1 and Scl/Tal1), as well as the early mesodermal
gene Brachyury (T) (Fig. 5B). These ﬁndings indicate this subpopula-
tion represents the hemangioblast population, present in vivo in
extraembryonic mesoderm. Cells negative for both Flk1 and ECD at
D3.5 expressed Brachyury and FoxA2, but not Runx1 or Scl/Tal1,
suggesting these cells represent non-hematopoietic/vascular
mesoderm.
To determine the potential of these mesodermal populations, we
deposited the Brachyury+ mesodermal ECDlowFlk1low and ECDlowFl-
k1high populations onto OP9 stromal cells in ESC differentiation
medium. Isolated from mouse calvaria, OP9 cells have been shown to
support differentiation of hematopoietic/vascular and cardiac cell
types (Nishikawa et al., 1998; Yamashita et al., 2005). After 3 days in
culture, the ECDlowFlk1high population developed into groups of round
cells, while ECDlowFlk1low cells formed densely packed colonies (Figs.
5C, D). After 6 days, contracting colonies appeared from ECDlowFlk1low
cells, not from ECDlowFlk1high cells (Figs. 5E ,F). In addition, X-Gal
staining of D3.5 ECDlowFlk1low and ECDlowFlk1high cell populations
cultured for 6 days indicated endocardial differentiation only occurredfrom the cultured D3.5 ECDlowFlk1low fraction (Fig. 5F). Immuno-
ﬂuorescence conﬁrmed that ECDlowFlk1high cells did not generate any
cardiomyocytes (Figs. 5G, H).
Molecular expression analysis of D3.5 ECDlowFlk1low and
ECDlowFlk1high cells after 6 days demonstrated that cardiac genes
(Nkx2.5, βMHC, Tbx5, cTnT, GATA4, andMef2c) present in ECDlowFlk1low
colonies, were absent or reduced in the D3.5 presort and
ECDlowFlk1high fraction (Fig. 5I). While vascular cells expressing
Flk1, VE-cadherin, and CD31/Pecam-1 were observed in cultures
derived from both populations, markers of hematopoietic develop-
ment (βH1-globin andGATA1)were only seen from the ECDlowFlk1high
population. In contrast, NFATc1 andNeuregulin1 (Nrg1), markers of the
endocardium, were only observed in colonies generated from
ECDlowFlk1low cells with myocardial differentiation. These studies
clarify that endocardium is not speciﬁed from the mesoderm that
generates the hemangioblast population in contrast to a zebraﬁsh
model where endocardium shares a common precursor with the
hematopoietic lineage (Bussman et al., 2007).
Endocardial endothelium is derived from an Flk1+ mesoderm
population with cardiovascular potential
Speciﬁcation of cardiac mesoderm follows differentiation of the
blood and vascular lineages in murine embryogenesis and EBs (Iida
et al., 2005; Kattman et al., 2006; Tam et al., 1997). To determine
Fig. 5. Hematopoietic/vascular and cardiac mesodermal precursors from differentiating ESCs. (A) Serum stimulated embryoid bodies disassociated and sorted at D3.5 by ﬂow
cytometry into fractions based on expression of Flk1 and ECD. (B) RT-PCR of isolated D3.5 populations for markers of primitive ectoderm, neuroectoderm, endoderm, mesoderm, the
early hematopoietic/vascular lineage. Controls included D3.5 presort EBs and H2O. (C–H) ECDlowFlk1high and ECDlowFlk1low fractions were deposited onto OP9 stromal cells serum-
containing differentiationmedium. Phase contrast images of characteristic groups of round ECDlowFlk1high cells (C) and densely packed ECDlowFlk1low cells (D) after 3 days of culture.
After 6 days of culture on OP9 feeders, contracting regions (black arrowheads) appeared from ECDlowFlk1low cells (F), but not in ECDlowFlk1high cells (E). X-Gal staining demonstrated
endocardial differentiation was only detected in ECDlowFlk1low cultured cell fractions. Immunoﬂuorescence of CD31/Pecam-1 (green) and MHC (red) expression in cultured D3.5
ECDlowFlk1high (G) and ECDlowFlk1low populations (H) after 6 days on OP9 cells. No cardiomyocyte differentiation was detected from the ECDlowFlk1high cell population. (I) Gene
expression analysis of ECDlowFlk1high and ECDlowFlk1high populations after 6 days of culture on OP9 stromal cells demonstrating blood and vascular differentiation in the
ECDlowFlk1high cells, with endocardial and myocardial gene expression restricted to the ECDlowFlk1low population. D3.5 presort EBs, D10 EBs cultured intact on gelatin, and H2O
represent controls. Second heart ﬁeld, SHF.
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D3.5 ECDlowFlk1high subpopulation, we re-cultured this fraction in
DM with bFGF (30 ng/ml) and VEGF (5 ng/ml) on OP9 stromal cells,
and resorted for Flk1 expression 24 h later (Fig. 6A). Isolated cells
were cultured on OP9 stromal cells and cultured in serum-free
media supplemented with VEGF (5 ng/ml), bFGF (30 ng/ml), BMP4
(50 ng/ml), and Dkk-1 (150 ng/ml), as previously described
(Kattman et al., 2006). The number of contracting colonies present
after 6 days of culture was signiﬁcantly higher in the D4.5 Flk1+
population compared to the D4.5 Flk1− cells (Fig. 6B). Dual β-gal/
immunoperoxidase staining of D4.5 Flk1+ and Flk1− populations
derived from NFATc1-nuc-LacZ BAC ESC demonstrated cardiomyocyte
and endocardial differentiation in D4.5 Flk1+ cells; no signiﬁcant endo-
cardial or myocardial differentiationwas seen from the D4.5 Flk1− cells
(Fig. 6C).
Examining D4.5 Flk1+ cells after 2, 4, and 6 days in culture, we
observed early cardiac transcription factors Nkx2.5 and Isl1 were
detectable by day 2 (Fig. 6D). While Nkx2.5 expression increased, Isl1
was downregulated at later time points. Other early markers of
cardiomyocyte differentiation, Tbx5 and Mef2c, were readily detect-
able by day 4. In addition, cardiac contractile proteins (βMHC and
cTnT) were present, indicating functional maturation of cardiomyo-
cytes. Most importantly, genes restricted to endocardial endothe-
lium, NFATc1 and Nrg1 were also present in cultures derived from
D4.5 Flk1+ cells. Vascularmarkers (Flk1,VE-cadherin, andCD31/Pecam-
1) became more pronounced over the course of differentiation. The
absence of the hematopoietic lineage markers GATA1 and βH1-globinindicated that D4.5 Flk1+ cells represented a unique population, not just
Flk1+ hemangioblasts that failed to be identiﬁed during the earlier sort.
Taken together, these ﬁndings suggest endocardium is generated from a
multipotent Flk1+ cardiovascular progenitor population that arises from
a temporally deﬁned mesoderm population.
Clonal analysis of Flk1+ multipotent cardiovascular progenitors indicate
endocardium from the same precursor
As the D4.5 Flk1+ fraction could contain separate Flk1+
endocardial and myocardial precursors, we performed clonal analysis
to determine the potential of a given cell. Individual D4.5 Flk1+ cells
from the NFATc1-nuc-LacZ BAC ESC line were deposited by ﬂow
cytometry onto OP9 feeders in serum-free medium supplemented
with VEGF, bFGF, BMP4, and Dkk-1. After 7 days, colonies were
stained and scored for cardiomyocytes, endothelium, smooth muscle,
and endocardium (MHC, CD31/Pecam-1, SM-MHC, and β-gal,
respectively). Nearly 50% (42 of 90) of colonies were positive for all
four cardiovascular cell lineages (Figs. 7A, B). Endocardial differentia-
tion was only detected in the presence of cardiomyocytes, never in
their absence. Also, not all endothelial cells that differentiated with
cardiomyocytes were endocardial cells. Thirty-one percent of colo-
nies (28 of 90) consisted of only myogenic cell types, cardiomyocytes
and smooth muscle, suggesting they were derived from a bipotential
myogenic cell population. Colonies of endothelium with or without
smooth muscle represented another 15%. The ability of individual
Flk1+ cells to generate these varied cardiovascular lineages provides
Fig. 6. Isolation and characterization of Flk1+ multipotent cardiovascular progenitors. (A) D3.5 embryoid bodies differentiated in serum-containing medium disassociated and
sorted with Flk1 and ECD. ECDlowFlk1low cells were cultured for 24 h on OP9 cells in serum-free mediumwith bFGF and VEGF before undergoing a second sort with Flk1. (B) Resorted
Flk1 positive and negative cells were plated at a density of 1×103 cells/cm3 onto OP9 cells in a 24-well dish in serum-free medium supplemented with VEGF, bFGF, BMP4, and Dkk-1.
The number of contracting colonies per well was scored after 6 days in culture. ⁎pb .05 vs. control,N=12. Error bars indicate SEM. (C) Dual β-gal/immunoperoxidase staining of D4.5
Flk1+ and Flk1− populations from NFATc1-nuc-LacZ BAC ESCs after 6 days of culture to demonstrate cardiomyocyte (cTnT, brown) and endocardial (β-gal; blue) differentiation. (D)
Gene expression proﬁle of D4.5 Flk1+ cells after 2, 4, and 6 days in culture examining endocardial, cardiac, vascular, and hematopoietic markers with D3.5 Flk1+ cultured for 6 days,
D10 EBs cultured intact on gelatin, and H2O as controls.
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common mesodermal cardiovascular precursor distinct from blood
and vascular populations.
Discussion
Despite the progress made in understanding the mechanisms of
cardiomyocyte lineage speciﬁcation, the origin of endocardial
endothelium and its developmental relationship to myocardium has
remained elusive. The generation of a novel transgenic marker using
promoter and enhancer elements of NFATc1 has enabled us to monitor
endocardiogenesis both in vivo, in the developing mouse embryo, as
well as in vitro during ESC differentiation. In this study, we establish
that endocardium is a discrete cardiac lineage distinct from other
vascular populations. Most importantly, we provide evidence that
endocardium is derived from a Flk1+ multipotent cardiovascular
progenitor, conﬁrming that in the mouse the endocardial and
myocardial lineages do not originate as separate populations that
migrate into juxtaposition as suggested by recent studies in zebraﬁsh
(Bussmann et al., 2007).
To deﬁne the process of endocardial differentiation, we utilized the
robust expression of Flk1 to identify mesoderm that contributes to
extraembryonic blood and vascular lineages, as well as endocardium
and myocardium (Motoike et al., 2003; Shalaby et al., 1995). The
utility of Flk1 for the purpose of isolating mesodermal precursor
populations has been well described (Fehling et al., 2003; Kattman et
al., 2006; Yamashita et al., 2005). In our studies, Flk1+ cells isolated
from D3.5 EBs generated hematopoietic and vascular cells, but did notexpress endocardial or myocardial transcripts, whichwere enriched in
the ECDlowFlk1low fraction. These ﬁndings are in agreementwith those
made by Kouskoff et al., where cardiac speciﬁcation was enriched in
Flk1-GFP-Byr+ cells after Flk1 depletion at D3.5, but absent when
Flk1+ cells were isolated at D4–D4.5 (Kouskoff et al., 2005). From
these observations and our RT-PCR analysis, the ECDlowFlk1high
population isolated at D3.5 represents a precursor population of the
hematopoietic/vascular lineage, while the ECDlowFlk1low fraction
contains cardiac mesodermal progenitors.
Given the temporal delay of cardiac progenitors exiting the PS
compared to extraembryonic mesoderm, as well as the observed delay
of Flk1 expression in mesodermal cells contributing to the cardiac
crescent compared to those generating the hematopoietic and
vascular cells, we resorted the ECDlowFlk1low population a day later
(Ema et al., 2006; Kinder et al., 1999). This population of Flk1+ cells
was enriched for cells with cardiac potential, forming contracting
colonies 6-fold over colonies generated from D4.5 Flk1− cells. After
2 days in culture expression of early markers of the ﬁrst and second
heart ﬁelds, Nkx2.5 and Isl1 could be detected, but expression of
endocardial markers was minimal. Similar to an analogous study of
Flk1+ cardiovascular progenitors, Isl1 was downregulated over time
with further differentiation, in a process previously attributed to
inadequate culture conditions to support derivatives of the second
heart ﬁeld (Kattman et al., 2006). Endocardial transcripts, NFATc1 and
Nrg1, were detected after 5 or 6 days in culture, relatively late, though
still subsequent to the onset of Nkx2.5 and Isl1 expression. We
postulate that there is a critical threshold of myocardial cell
differentiation necessary to induce endocardial differentiation. It
Fig. 7. Clonal analysis of endocardial and myocardial potential in Flk1+ multipotent cardiovascular progenitors. (A) Individual D4.5 Flk1+ cells from NFATc1-nuc-LacZ BAC ESCs
deposited by ﬂow cytometry into 96-well plates seeded with OP9 stromal cells in serum-free medium supplemented with VEGF, bFGF, BMP4, and Dkk-1. After 7 days, colonies were
stained and scored for the presence of endocardium (Ec), cardiomyocytes (Cm), endothelium (Et), and smooth muscle (Sm). (B) Representative image of Flk1+ multipotent
cardiovascular progenitor clone stained for endocardium (β-gal, green), cardiomyocytes (MHC), endothelium (CD31, blue), and smooth muscle (SM-MHC, purple). (C) Model of
cardiovascular lineage speciﬁcation from mesodermal progenitors. See Discussion for details.
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autonomous differentiation program, cell-to-cell contact, or by
paracrine signaling interactions.
In assessing the clonal potential of the D4.5 Flk1+ population, we
demonstrated their ability to form myocardium, endocardium,
endothelium, and smooth muscle. While myocardial and endocardial
cells are both generated from these progenitors, not all observed
endothelial cells were endocardium. This diversity reﬂects the actual
endothelial heterogeneity seen in the developing heart. Interestingly,
endocardial cells are only detected in the presence of cardiomyocytes.
While these studies indicate individual Flk1+ cardiovascular
progenitors have the ability to generate multiple cell types, the exact
mechanism(s) regulating the divergence of these lineages is unknown.
It has been asserted that there exists reciprocal signaling between
cardiac and hematopoietic/vascular lineages that acts to restrict
lineage-speciﬁc expression (Schoenebeck et al., 2007). One example of
this is the Ets transcription factor Er71, which has been identiﬁed to act
on Flk1+ mesoderm to promote hematopoietic and vascular cell
speciﬁcation at the expense of cardiac differentiation (Lee et al., 2008).
In addition, Er71 (Etsrp71) has recently been implicated as a regulator
of endocardial and endothelial fate from cardiac progenitors. Ferdous
et al. (2009) demonstrated that Nkx2.5, previously thought to
primarily regulate myocardial transcriptional activation, binds to an
evolutionarily conserved homeodomain element in the Er71 promoter
to activate endocardial and endothelial differentiation. These studies
suggest that activation of a single transcriptional network within
cardiovascular progenitors might be responsible for regulating both
endocardial and myocardial speciﬁc transcriptional events. Future
molecular analyses will continue to provide insight into the transcrip-
tional regulation of endocardial cell speciﬁcation.The ﬁndings presented here build on recent work establishing a
stepwise, hierarchical model of cardiac lineage diversiﬁcation. We
propose a working model of cardiac differentiation from multipotent
progenitors where endocardial cells are a unique cardiac lineage (Fig.
7C). Flk1+, Nkx2.5+, and Isl1+ multipotent cardiovascular progeni-
tors capable of generating cardiomyocytes, endothelium, and smooth
muscle have been described. Our ﬁndings, coupled with fate mapping
studies, indicate that endocardial cells are derived from these
progenitors. Further speciﬁcation of these progenitors creates endo-
cardial, myogenic, and systematic vascular lineages. Flk1+ progeni-
tors for vascular smooth muscle and endothelium have been
documented, as have Nkx2.5+ c-kit+ bipotential precursors of the
myogenic lineage (Ema et al., 2003; Wu et al., 2006; Yamashita et al.,
2000). In contrast, endocardial cells maintain Flk1 and NFATc1
expression, while downregulating primitive myocardial genes.
Given the abundance of evidence emphasizing the role of
endocardial–myocardial interactions in regulating later cardiac
morphogenic events, elucidating how these two lineages interact at
the earliest stages of development is essential. Particularly intriguing
are experimental studies suggesting paracrine signals from the
endocardium to the myocardium during development can rescue
genetic defects of myocardium that are lethal in utero (Chien et al.,
2004; Fraidenraich et al., 2004). Having identiﬁed the endocardium
as a unique subpopulation of endothelium at the earliest stages of
differentiation, our studies provide essential insights required to
further investigate the unique characteristics of endocardial speciﬁ-
cation and differentiation that are essential for understanding basic
processes of heart development and congenital heart disease.
Furthermore, they provide a framework to evaluate the potential
for manipulation of endocardial–myocardial interactions during
88 A.M. Misfeldt et al. / Developmental Biology 333 (2009) 78–89differentiation as a strategy to enhance the regenerative potential of
stem cell based replacement therapy.
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